Skip to main content
Caplight Logo









Xsolis

Xsolis

Private
Franklin, TennesseeHealthcare & Life Scienceshttps://www.xsolis.com/

Last Round

Growth Equity

Jun 28, 2021

Total Funding Raised

$75M

Company Overview

Xsolis is a healthcare technology company that provides an AI-driven software platform designed to enhance collaboration between healthcare providers and payers through real-time transparency and predictive analytics.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Revenue Cycle, Medical AI, EHR & EMR, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

utilization managementrevenue cycle managementclinical decision supportdenial managementmedical necessityphysician advisory serviceselectronic health recordEHRhealthcare AIpayer-provider collaborationcase management softwarerevenue integrityhealth techclaims denial preventionclinical workflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xsolis Comparables

Compare Xsolis with similar companies based on industry and business-model similarity.

Xsolis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hearst Communications
79%
UnitedHealth Group
76%
Cohere Health
71%

Xsolis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 28, 2021

Key People

Founding team and executive leadership

Joan Butters

CEO

Executive Team

Zach Evans

Chief Technology Officer

Executive Team

Rachel Vincion

Chief Financial Officer

Executive Team

Vic Pierni

Chief Financial Officer

Executive Team

Xsolis Investors

Notable investors and investment history

Xsolis investors
InvestorRounds
Nashville Capital NetworkVC Round
Brighton Park CapitalGrowth Equity
Relevance VenturesVC Round
Powered HealthVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2025

    Monthly visitors increased 35% MoM, reaching 13.2K.

  • Jun 28, 2021

    $75M round led by Brighton Park Capital

Xsolis Filings

Explore SEC and related filing metadata, where available.

Xsolis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xsolis's valuation, stock price, and market status.

Is Xsolis a public or private company?

Xsolis is a private company.

What is the current stock price of Xsolis?

Xsolis is a private company with no public stock price. No recent secondary market data is available.

How much is Xsolis worth (valuation)?

Valuation information for Xsolis is not publicly available.

Can I buy Xsolis stock?

Xsolis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xsolis's last funding round?

Funding round information for Xsolis is not publicly available.

Who are the main investors in Xsolis?

Investor information for Xsolis is not publicly disclosed.

Will Xsolis IPO soon?

No public IPO plans have been announced for Xsolis.

How can I track Xsolis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xsolis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFranklin, Tennessee
Employee Range239
Year Founded2013
Last FundingJun 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?